2020-JTI-IMI2-2017-13-TWO-STAGE

OBJECTIVES OF THE FUNDING PROGRAMMEThe Innovative Medicines Initiative is a jointly funded partnership between the European Union, represented by the European Commission, and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The Innovative Medicines Initiative 2 Joint Undertaking (IMI2 JU) has been created following the principles below:• Research related to the future of medicine should be undertaken in areas where societal, public health and biomedical industry competitiveness goals are aligned and require the pooling of resources and greater collaboration between [...]